BMEYE (Netherlands) a commercial-stage hemodynamic monitoring device company focused on finger arterial pressure and cardiac output technologies, closed a $8.6M Series B financing. Participants includeEarlybird, 360 Capital Partners, Life Sciences Partners and Techfund.

Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb